Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/Harapan Kita National Cardiovascular Centre, Jakarta, Indonesia.
Glob Heart. 2023 Aug 10;18(1):42. doi: 10.5334/gh.1253. eCollection 2023.
Cardiac rehabilitation (CR) reduces mortality and morbidity in coronary heart disease (CHD); however, patients show a lack of adherence to CR. Alternatively, telehealth interventions have shown promising results for improving target outcomes in CR. This study aimed to review the effect of smartphone-based CR on the functional capacity of CHD patients. A literature search was performed using PubMed, MEDLINE, Embase, and Cochrane Library on 21 March, 2022 to find randomised controlled trials on smartphone usage in CR to improve functional capacity. Outcomes included maximal oxygen consumption (VO max), a 6-min walk test (6-MWT), quality of life, smoking cessation, and modifiable risk factors. Eleven trials recruiting CHD patients were reviewed. Wearable devices connected to smartphone- or chat-based applications were commonly used for CR delivery. Most trials managed to provide exercise prescriptions, education on medication adherence and controlling risk factors, and psychosocial counselling through the intervention. Functional capacity improved significantly following smartphone-based CR in CHD patients compared to control groups, as measured by VO max and 6-MWT; patients were more likely to quit smoking. Compared to traditional care, smartphones that delivered CR to CHD patients demonstrate superior outcomes regarding increasing functional capacity. There is no significant improvement on lipid profile, blood pressure, HbA1C, body mass index, and quality of life. It can be used either alone or as an adjunct. Ultimately, the patients' preferences and circumstances should be considered.
心脏康复(CR)可降低冠心病(CHD)患者的死亡率和发病率;然而,患者对 CR 的依从性较差。另一方面,远程医疗干预在改善 CR 的目标结果方面显示出良好的效果。本研究旨在综述基于智能手机的 CR 对 CHD 患者功能能力的影响。于 2022 年 3 月 21 日在 PubMed、MEDLINE、Embase 和 Cochrane Library 上进行文献检索,以查找有关智能手机在 CR 中使用以改善功能能力的随机对照试验。结果包括最大摄氧量(VO max)、6 分钟步行试验(6-MWT)、生活质量、戒烟和可改变的危险因素。共综述了 11 项招募 CHD 患者的试验。可穿戴设备与智能手机或基于聊天的应用程序连接,通常用于 CR 输送。大多数试验设法通过干预提供运动处方、药物依从性和控制危险因素方面的教育以及心理社会咨询。与对照组相比,智能手机为 CHD 患者提供的 CR 可显著提高患者的功能能力,VO max 和 6-MWT 均有改善;患者更有可能戒烟。与传统护理相比,为 CHD 患者提供 CR 的智能手机在增加功能能力方面显示出更好的效果。对血脂谱、血压、HbA1C、体重指数和生活质量没有显著改善。它可以单独使用或作为辅助使用。最终,应考虑患者的偏好和情况。